Prior Antithrombotic Therapy Is Associated With Cerebral Microbleeds in Ischemic Stroke Patients With Atrial Fibrillation and/or Rheumatic Heart Disease

Prior Antithrombotic Therapy Is Associated With Cerebral Microbleeds in Ischemic Stroke Patients With Atrial Fibrillation and/or Rheumatic Heart Disease

Background and purpose: Cerebral microbleeds (CMBs) could contribute to an increased risk of intracerebral hemorrhage in patients with antithrombotic therapy (antiplatelets or anticoagulants). Antithrombotic agents are commonly prescribed to the patients with atrial fibrillation (AF) and/or rheumati...

Full description

Bibliographic Details
Main Authors: Yajun Cheng, Junfeng Liu, Shuting Zhang, Jie Li, Chenchen Wei, Deren Wang, Jing Lin, Yanan Wang, Bo Wu, Shihong Zhang, Ming Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-01-01
Series:Frontiers in Neurology
Subjects:
antithrombotic therapy
cerebral microbleeds
ischemic stroke
atrial fibrillation
rheumatic heart disease
Online Access:https://www.frontiersin.org/article/10.3389/fneur.2018.01184/full

Internet

https://www.frontiersin.org/article/10.3389/fneur.2018.01184/full

Similar Items